Datt Mediproducts Ltd
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE 8.19 %
- ROE 7.00 %
- Face Value ₹ 10.0
Pros
Cons
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.1.70 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|
| 56.45 | 59.46 | 68.04 | |
| 52.53 | 56.79 | 64.20 | |
| Operating Profit | 3.92 | 2.67 | 3.84 |
| OPM % | 6.94% | 4.49% | 5.64% |
| 1.59 | 2.54 | 1.70 | |
| Interest | 0.72 | 1.45 | 1.52 |
| Depreciation | 1.89 | 1.99 | 1.94 |
| Profit before tax | 2.90 | 1.77 | 2.08 |
| Tax % | 0.34% | 23.16% | 38.46% |
| 2.89 | 1.36 | 1.27 | |
| EPS in Rs | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|
| Equity Capital | 13.22 | 13.22 | 13.22 |
| Reserves | 3.50 | 4.86 | 6.14 |
| 22.33 | 24.56 | 27.13 | |
| 8.26 | 9.58 | 11.54 | |
| Total Liabilities | 47.31 | 52.22 | 58.03 |
| 20.58 | 20.52 | 20.42 | |
| CWIP | 0.05 | 0.05 | 0.07 |
| Investments | 0.77 | 0.81 | 1.88 |
| 25.91 | 30.84 | 35.66 | |
| Total Assets | 47.31 | 52.22 | 58.03 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|
| 3.52 | 0.31 | 2.99 | |
| -2.83 | -1.99 | -3.21 | |
| -0.72 | 2.19 | 1.13 | |
| Net Cash Flow | -0.03 | 0.51 | 0.91 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|
| Debtor Days | 43.64 | 52.61 | 56.22 |
| Inventory Days | 195.02 | 214.89 | 236.61 |
| Days Payable | 55.90 | 50.26 | 60.68 |
| Cash Conversion Cycle | 182.77 | 217.24 | 232.15 |
| Working Capital Days | 109.73 | 126.27 | 123.22 |
| ROCE % | 7.88% | 8.19% |
Documents
Announcements
No data available.
Annual reports
No data available.